Nu Skin Enterprises, Inc. (NYSE:NUS) released its quarterly earnings results on Wednesday. The company reported $0.76 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.76, Bloomberg Earnings reports. The firm had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. Nu Skin Enterprises’s quarterly revenue was down 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.98 EPS. Nu Skin Enterprises updated its Q4 guidance to $1.16-$1.21 EPS and its FY17 guidance to $3.20-$3.25 EPS.

WARNING: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/11/01/nu-skin-enterprises-inc-nus-announces-earnings-results.html.

In other news, President Ryan S. Napierski sold 6,933 shares of Nu Skin Enterprises stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total transaction of $443,712.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Daniel W. Campbell sold 4,607 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $62.48, for a total value of $287,845.36. Following the sale, the director now directly owns 63,753 shares in the company, valued at approximately $3,983,287.44. The disclosure for this sale can be found here. Insiders have sold a total of 19,040 shares of company stock worth $1,188,157 in the last three months. 5.20% of the stock is owned by insiders.

A number of equities analysts have weighed in on the company. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 price target on Nu Skin Enterprises and gave the stock a “sell” rating in a report on Thursday, August 3rd. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Bank of America Corporation upped their price target on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a report on Monday, July 10th. Finally, Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Wednesday, July 5th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the stock. Nu Skin Enterprises has a consensus rating of “Hold” and a consensus price target of $62.00.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.